| Drug Name |
Levalbuterol hydrochloride |
| Drug ID |
BADD_D01263 |
| Description |
Levosalbutamol, or levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
[Salbutamol] has been marketed as a racemic mixture, although beta2-agonist activity resides almost exclusively in the (R)-enantiomer. The enantioselective disposition of salbutamol and the possibility that (S)-salbutamol has adverse effects have led to the development of an enantiomerically pure (R)-salbutamol formulation known as levosalbutamol (levalbuterol). |
| Indications and Usage |
Levosalbutamol's bronchodilator properties give it indications in treatment of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma. |
| Marketing Status |
Prescription |
| ATC Code |
Not Available |
| DrugBank ID |
DB13139
|
| KEGG ID |
D02281
|
| MeSH ID |
D064412
|
| PubChem ID |
123601
|
| TTD Drug ID |
D02ZJI
|
| NDC Product Code |
0115-9931; 66993-021; 76204-800; 17478-174; 17337-0524; 17478-172; 17478-171; 35573-445; 0115-9930; 0115-9932; 76204-700; 35573-443; 53104-7719; 51927-5157; 66993-022; 76204-900; 66993-023; 48954-719; 17478-173; 35573-444; 68071-5027; 15308-0310 |
| Synonyms |
Levalbuterol | Xopenex | Levalbuterol Hydrochloride | Hydrochloride, Levalbuterol | Levosalbutamol Hydrochloride | Hydrochloride, Levosalbutamol |
